Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors

Investigational New Drugs

Volumn 25, Issue 6, 2007, Pages 519-524

  Mueller, Sandra ^a   Hartmann, Ulrike ^a   Mayer, Frank ^a   Balabanov, Stefan ^a,b   Hartmann, Joerg T ^a   Brummendorf, Tim H ^a,b   Bokemeyer, Carsten ^a,b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

BIBR1532; Cisplatin; Germcell tumors (GCTs); In vitro; Telomerase inhibition; Telomere length

Indexed keywords

AMINOBENZOIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; BIBR 1532; CISPLATIN; NAPHTHALENE DERIVATIVE; TELOMERASE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MALE; METABOLISM; NEOPLASM; TELOMERE; TUMOR CELL LINE;

AMINOBENZOIC ACIDS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DRUG SYNERGISM; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NAPHTHALENES; NEOPLASMS, GERM CELL AND EMBRYONAL; TELOMERASE; TELOMERE;

EID: 39549117432     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/s10637-007-9063-6     Document Type: Article

References (28)

1. Pottern ML, Brown M, Devesa SS (1998) Epidemiology and pathogenesis of testicular caner. In Ernsthoff MS, Heaney JA, Peschel RE (eds.) Testicular and penile cancer. Blackwell Science, Oxford, pp 2-10.
2. Bosl GJ, Motzer RJ (1997) Testicular germ-cell cancer. N Engl J Med 337:242-253
3. Mayer F, Honecker F, Looijenga LH, Bokemeyer C (2003) Towards an understanding of the biological casis of response to cisplatin-based chemotherapy in germ-cell tumors. Ann Oncol 14:825-832 (Pubitemid 36827197)
4. Oosterhuis JW, Looijenga LH (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5:210-222 (Pubitemid 40314952)
5. Blackburn EH (1991) Telomeres. Trends Biochem Sci 16:378-381
6. Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460
7. Greider CW (1998) Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 95:90-92
8. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18:173-179
9. Albanell J, Bosl GJ, Reuter VE, Engelhardt M, Franco S, Moore MA, Dmitrovsky E (1999) Telomerase activity in germ cell cancers and mature teratomas. J Natl Cancer Inst 91:1321-1326 (Pubitemid 29387575)
10. Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J (1987) Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10:19-28 (Pubitemid 17081837)
11. Nowak R, Sikora K, Pietas A, Skoneczna I, Chrapusta SJ (2000) Germ cell-like telomeric length homeostasis in nonseminomatous testicular germ cell tumors. Oncogene 19:4075-4078
12. Kiyozuka Y, Yamamoto D, Yang J, Uemura Y, Senzaki H, Adachi S, Tsubura A (2000) Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells. Anticancer Res 20:203-212 (Pubitemid 30189755)
13. Ishibashi T, Lippard SJ (1998) Telomere loss in cells treated with cisplatin. Proc Natl Acad Sci USA 95:4219-4223 (Pubitemid 28207892)
14. Damm K, Hemmann U, Garin-Chesa P, Hauel N, Kauffmann I, Priepke H, Niestroj C, Daiber C, Enenkel B, Guilliard B, Lauritsch I, Muller E, Pascolo E, Sauter G, Pantic M, Martens UM, Wenz C, Lingner J, Kraut N, Rettig WJ, Schnapp A (2001) A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J 20:6958-6968 (Pubitemid 34062288)
15. Wang N, Perkins KL, Bronson DL, Fraley EE (1981) Cytogenetic evidence for premeiotic transformation of human testicular cancers. Cancer Res 41:2135-2140 (Pubitemid 11111406)
16. 50-values and cell survival.Eur J Clin Chem Clin Biochem 33:813-823
17. Koch S, Mayer F, Honecker F, Schittenhelm M, Bokemeyer C (2003) Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro. Br J Cancer 89:2133-2139 (Pubitemid 38030914)
18. Baerlocher GM, Mak J, Tien T, Lansdorp PM (2002) Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry 47:89-99 (Pubitemid 34117038)
19. Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM (1998) Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol 16:743-747 (Pubitemid 28363755)
20. Rufer N, Brummendorf TH, Kolvraa S, Bischoff C, Christensen K, Wadsworth L, Schulzer M, Lansdorp PM (1999) Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 190(2):157-167 (Pubitemid 29354909)
21. Hartmann U, Balabanov S, Ziegler P, Fellenberg J, van der KH, Duyster J, Lipp HP, Bokemeyer C, Kanz L, Brummendorf TH (2005) Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib. Exp Hematol 33:542-549 (Pubitemid 40592170)
22. Gonzalez-Quevedo R, de Juan C, Massa MJ, Sanchez-Pernaute A, Torres A, Balibrea JL, Benito M, Iniesta P (2000) Detection of telomerase activity in human carcinomas using a trap-ELISA method: correlation with hTR and hTERT expression. Int J Oncol 16:623-628
23. Wu YY, Hruszkewycz AM, Delgado RM, Yang A, Vortmeyer AO, Moon YW, Weil RJ, Zhuang Z, Remaley AT (2000) Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays. Clin Chim Acta 293:199-212 (Pubitemid 30103567)
24. El Daly H, Kull M, Zimmermann S, Pantic M, Waller CF, Martens UM (2005) Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532. Blood 105:1742-1749 (Pubitemid 40223698)
25. Pascolo E, Wenz C, Lingner J, Hauel N, Priepke H, Kauffmann I, Garin-Chesa P, Rettig WJ, Damm K, Schnapp A (2002) Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate. J Biol Chem 277:15566-15572 (Pubitemid 34967825)
26. Josephson R, Ording CJ, Liu Y, Shin S, Lakshmipathy U, Toumadje A, Love B, Chesnut JD, Andrews PW, Rao MS, Auerbach JM (2007) Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research. Stem Cells 25:437-446 (Pubitemid 46232799)
27. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL, Knoll JH, Meyerson M, Weinberg RA (1999) Inhibition of telomerase limits the growth of human cancer cells. Nat Med 5:1164-1170 (Pubitemid 29474421)
28. Ward RJ, Autexier C (2005) Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment. Mol Pharmacol 68:779-786 (Pubitemid 41206032)